Review Article

Meta-Analysis of the Correlation between Apparent Diffusion Coefficient and Standardized Uptake Value in Malignant Disease

Table 2

MRI characteristics, cancer types, and values.

AuthorYear Nation Number of patients Number of tumorsTumor Age Design Field Index value (s/m2)

Mori et al. [8]2008Japan104140Lung (various)AdultProspective1.5 T1000−0.504
Ho et al. [9]2009Taiwan3333Cervix (various)AdultProspective3.0 T/0 and 1000−0.526
Palumbo et al. [10]2009USA1518Brain (metastases)AdultN1.5 TADC-CRN−0.524
Aoyagi et al. [11]2010Japan123123Esophageal (SCC)AdultN1.5 TADC0 and 1000−0.398
Nakajo et al. [12]2010Japan4444Breast (ductal carcinoma)AdultRetrospective1.5 T0 and 1000−0.486
Punwani et al. [13]2010UK1653Lymphoma (MCL)ChildrenN1.5 T500−0.38
Tanimoto et al. [14]2010Japan1616Pancreas (various)AdultN3.0 TADC400, 800, and 1200−0.48
Choi et al. [15]2011Korea4747Head and neck (SCC)AdultRetrospective1.5 T1000−0.222
Fruehwald-Pallamar et al. [16]2011Austria3131Head and neck (SCC)AdultProspective3.0 T0 and 800−0.238
Gu et al. [17]2011China3333Rectum (adenocarcinoma)AdultN3.0 T0 and 1000−0.45
Ohba et al. [18]2011Japan5876Lung (various)NProspective1.5 T1000−0.31
Usuda et al. [19]2011Japan6363Lung (various)AdultN1.5 T0 and 800−0.286
Wu et al. [20]2011Finland1515Lymphoma (DLBCL)AdultProspective3.0 T0 and 8000.215
Cafagna et al. [21]2012Italy3888VariousNRetrospective1.5 TADC500 and 10000.238
Choi et al. [22]2012Korea118118Breast (IDC)AdultN1.5 and 3.0 T0, 750, and 1000−0.025
Matsushima et al. [23]2012Japan3636Glioma and lymphomaChildren and adultRetrospective1.5 T1000−0.68
Nakajo et al. [24]2012Japan2626Head and neck (SCC)AdultRetrospective1.5 T0 and 800−0.566
Nakamatsu et al. [25]2012Japan2441Metastatic neck lymph nodes of head and neck (SCC)AdultRetrospective1.5 T0 and 1000−0.489
Nakamura et al. [26]2012Japan6666Cervix (various)AdultN1.5 T0, 50, and 1000−0.529
Regier et al. [27]2012Germany4141Lung (NSCLC)NProspective1.5 T0 and 500−0.46
Ahn et al. [28]2013Korea2121Liver (HCC)AdultRetrospective3.0 T50, 400, and 8000.369
Byun et al. [29]2013Korea7575Breast (IDC)AdultRetrospective3.0 T0 and 800−0.267
Gong et al. [30]2013China721Metastatic GISTAdultRetrospective3.0 T0, 150, and 1000−0.843
Nakamura et al. [31]2013Japan131131EndometriaAdultProspective1.5 T0, 50, and 1000−0.677
Rakheja et al. [32]2013USA2469VariousAdultN3.0 T0, 350, and 750−0.29
Schmidt et al. [33]2013Germany1414Lung (various)AdultN3.0 T0 and 800−0.8
Tsuchida et al. [34]2013Japan2828Lung (various)AdultN1.5 TADC0 and 8000.043
Varoquaux et al. [35]2013Switzerland3334Head and neck (SCC)Children and adultRetrospective1.5 and 3.0 TADC0 and 1000−0.103
Baba et al. [36]2014Japan7983Breast (various)AdultRetrospective1.5 T1000−0.36
de Jong et al. [37]2014Netherlands2121Lymphoma (DLBCL)AdultProspective1.5 T0 and 1000−0.103
Er et al. [38]2014Turkey4141Rectum (adenocarcinoma)AdultRetrospective3.0 T50, 400, and 1000−0.347
Giganti et al. [39]2014Italy1717Gastric (adenocarcinoma)AdultProspective1.5 T0 and 600−0.01
Grueneisen et al. [40]2014Germany1554Cervix (various)AdultProspective3.0 T0, 500, and 1000−0.342
Iizuka et al. [41]2014Japan1515Lung (NSCLC)AdultN1.5 T0, 500, and 10000.046
Sakane et al. [42] 2015Japan2020Pancreas (adenocarcinoma)AdultRetrospective3.0 T0 and 800−0.66
Schwenzer et al. [43]2014Germany2052Peritoneal carcinomatosisAdultProspective3.0 T50 and 800−0.58
Sun et al. [44]2014China3535Cervix (various)AdultProspective3.0 T0, 200, 500, and 1000−0.505
Yu et al. [45]2014China834Peritoneal metastasesAdultProspective3.0 T0, 400, and 800−0.548
Zhang et al. [46]2014China113113Lung (various)AdultN3.0 T1000−0.37
Zukotynski et al. [47]2014USA3636Brain (BSG)ChildrenRetrospective1.5 T5 and 1000−0.54
Brandmaier et al. [48]2015Germany1414Cervix (various)AdultProspective3.0 T0 and 800−0.532
Covello et al. [49]2015Italy4444Head and neck (various)AdultN3.0 T0, 500, and 800−0.36
Han et al. [50]2015Korea3434Head and neck (SCC)AdultRetrospective1.5 T0 and 1000−0.333
Heacock et al. [51]2015USA1351Lymphoma (various)AdultProspective3.0 T0, 350, and 7500.06
Karan et al. [52] 2016Turkey7070Breast (IDC)AdultRetrospective1.5 T0, 200, 600, and 800−0.112
Littooij et al. [53]2015Netherlands1119Lymphoma (various)Children and adultProspective1.5 T0 and 1000−0.24
Liu et al. [54]2015China1111Lung (various)AdultN1.5 T1000−0.55
Metz et al. [55]2015Germany1212Lung (metastatic NSCLC)AdultProspective1.5 T50, 300, and 6000.3
Schaarschmidt et al. [56]2015Germany25100Lymph node metastases of NSCLCAdultRetrospective3.0 T0, 500, and 1000−0.36

SCC: squamous cell carcinoma; NSCLC: non-small cell lung cancer; MCL: mantle cell lymphoma; DLBCL: diffuse large B cell lymphoma; HCC: hepatocellular carcinoma; BSG: brain stem glioma; IDC: invasive ductal carcinoma; N: no report.